Monopar Therapeutics Inc. Share Price
MNPRMonopar Therapeutics Inc. Stock Performance
Open $62.21 | Prev. Close $62.74 | Circuit Range N/A |
Day Range $58.20 - $62.21 | Year Range $24.00 - $103.77 | Volume 8,096 |
Average Traded $59.25 |
Monopar Therapeutics Inc. Share Price Chart
About Monopar Therapeutics Inc.
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, a clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19. The company was founded in 2014 and is headquartered in Wilmette, Illinois.
Monopar Therapeutics Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
09-Jan-26 | $65.71 | $62.74 | -0.88% |
08-Jan-26 | $65.31 | $63.30 | -2.94% |
07-Jan-26 | $62.46 | $65.22 | +6.82% |
06-Jan-26 | $59.02 | $61.05 | -0.83% |
05-Jan-26 | $66.04 | $61.56 | -6.77% |
02-Jan-26 | $66.06 | $66.03 | +1.45% |
31-Dec-25 | $64.20 | $65.08 | +0.27% |
FAQs on Monopar Therapeutics Inc. Share Price
Can I buy Monopar Therapeutics Inc. shares in India?
What is the share price of Monopar Therapeutics Inc.?
What is the 5 year returns of Monopar Therapeutics Inc.?
What are the high & low stock price of Monopar Therapeutics Inc. today?
What is the 52-week high and low of Monopar Therapeutics Inc. stock?